• Mon, April 28, 2025

by: MarketBeat

3 Top Big Pharma Stocks Investing Over $100 Billion in the U.S.

Amid recession worries and tumbling markets; President Trump's tariffs are still helping the U.S. economy achieve key wins. Many huge corporations have announced plans to invest billions in U.S. manufacturing.

by: WOPRAI

Short squeeze is starting in shares of NEWTI at $24.91, after crossing above the $24.888 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of CDIOW at $0.033, after crossing above the $0.032 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of TTE at $60.32, after crossing above the $60.308 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of RHHBY at $40.26, after crossing above the $40.212 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of LADR at $10.385, after crossing above the $10.325 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of FSLR at $142.42, after crossing above the $142.265 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of EE at $26.63, after crossing above the $26.561 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of DHC at $2.325, after crossing above the $2.297 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of CETX at $1.41, after crossing above the $1.398 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of BTLCY at $5.145, after crossing above the $5.123 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of BSV at $78.485, after crossing above the $78.467 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of BNAI at $0.366, after crossing above the $0.363 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of UDR at $41.35, after crossing above the $41.341 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of TRNS at $85.825, after crossing above the $85.328 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of XNET at $4.53, after crossing above the $4.425 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of TXT at $69.42, after crossing above the $69.263 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of TSSI at $7.62, after crossing above the $7.61 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of TBTC at $4.14, after crossing above the $3.882 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of TAK at $15.135, after crossing above the $15.105 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of SLYG at $80.87, after crossing above the $80.866 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of SHCO at $5.93, after crossing above the $5.918 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of SATL at $3.92, after crossing above the $3.723 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of RIHT at $0.02, after crossing above the $0.019 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of PKBK at $18.905, after crossing above the $18.814 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of PCAR at $92.57, after crossing above the $92.379 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of OFS at $8.95, after crossing above the $8.903 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of OCUL at $8.13, after crossing above the $7.871 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of NWN at $44.13, after crossing above the $44.12 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of NTRS at $92.465, after crossing above the $91.75 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of MVSTW at $0.246, after crossing above the $0.237 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of KYMR at $33.635, after crossing above the $33.543 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of GSK at $37.9, after crossing above the $37.885 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of GRABW at $0.44, after crossing above the $0.421 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of DEA at $20.714, after crossing above the $14.542 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of CRNX at $33.47, after crossing above the $32.725 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of CPAY at $325.5, after crossing above the $323.74 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of COFS at $27.68, after crossing above the $27.522 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of CHA at $33, after crossing above the $32.7 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of BGH at $14.3, after crossing above the $14.258 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of ATS at $25.56, after crossing above the $25.301 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of WMS at $113.2, after crossing above the $112.844 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of GBDC at $14.516, after crossing above the $14.511 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of EICC at $24.98, after crossing above the $24.961 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of CYD at $15.8, after crossing above the $15.778 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of CODA at $7.06, after crossing above the $6.979 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of CBU at $57.18, after crossing above the $56.81 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of ALV at $91.98, after crossing above the $91.43 Trigger Price

3 Top Big Pharma Stocks Investing Over $100 Billion in the U.S.

Amid recession worries and tumbling markets; President Trump's tariffs are still helping the U.S. economy achieve key wins. Many huge corporations have announced plans to invest billions in U.S. manufacturing.
The article from MSN Money discusses three major pharmaceutical companies, Eli Lilly, Merck, and Bristol Myers Squibb, which are investing over $100 billion in the U.S. Eli Lilly is investing $3.7 billion in a new manufacturing facility in Indiana to increase production of its diabetes and obesity treatments, Mounjaro and Zepbound. Merck is committing $11 billion to expand its manufacturing capabilities in Virginia and North Carolina, focusing on cancer treatments like Keytruda. Bristol Myers Squibb is investing $10 billion in new facilities in Massachusetts and Washington to enhance its production of cancer therapies such as Opdivo and Eliquis. These investments are aimed at meeting growing demand, advancing research, and strengthening the U.S. economy through job creation and innovation in healthcare.

Read the Full MarketBeat Article at:
https://www.msn.com/en-us/money/markets/3-top-big-pharma-stocks-investing-over-100-billion-in-the-u-s/ar-AA1DLsvn

Like: 👍

Similar Stocks and Investing Publications
Investing in biotech stocks isn't for everyone because the very nature of their business is fraught with risk. As a result, biotech stocks can be highly volatile. However, some exceptions aren't nearly as risky.
Vancouver, Kelowna and Delta, British Columbia--(Newsfile Corp. - July 11, 2024) - Investorideas.com, a go-to investing platform releases the first of a two-part series looking at transformative innovation in biopharma, featuring Citius Pharmaceuticals, Inc. (NASDAQ: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products. The Company's diversified pipeline includes two late-stage product candidates.Read the full a